News & Trends - MedTech & Diagnostics
Private hospitals willing and able to help with pandemic

Australia’s private hospitals are ready and willing to assist public hospitals by taking on some of the elective surgery caseload as the COVID-19 pandemic continues to impact Australia’s health care system, says Australian Private Hospitals Association (APHA) CEO Michael Roff.
Mr Roff said there is capacity in private hospitals and a commitment from the private sector to play their part in ensuring Australians receive the care they need.
“The whole Australian health care system needs to work together to weather this potential crisis. Many states have already committed to addressing their elective surgery waiting lists with the help of the private hospital sector, we expect others will move to do the same.
“The private hospitals sector is working with States, Territories and the Federal Government to be part of the solution for Australia at this time. Private hospitals are in discussions with their local public hospitals, health districts and state health departments about matching capacity to potential need,” he said.
Customer engagement in COVID-19 times – Keep your people safe and maximise HCP reach and engagement digitally. Learn more about how we can help your team – solutions developed by industry for industry.
Mr Roff said there were some concerns about the availability of personal protective equipment to ensure surgery can go ahead, but this was also being discussed with government.
“It is essential the health care system in Australia mobilises together to ensure we are able to manage the impacts of the COVID-19 pandemic,” Mr Roff said.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board
Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]
MoreNews & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech
MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]
MoreNews & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?
Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]
More